{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:50:59Z","timestamp":1784357459293,"version":"3.55.0"},"reference-count":34,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.3892\/ijmm.2016.2828","type":"journal-article","created":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T12:40:43Z","timestamp":1481632843000},"page":"297-306","source":"Crossref","is-referenced-by-count":29,"title":["Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells"],"prefix":"10.3892","volume":"39","author":[{"given":"Yunpeng","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,12,13]]},"reference":[{"key":"key20180107234954_b1-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"50","DOI":"10.5492\/wjccm.v1.i2.50","article-title":"Acute respiratory distress syndrome and lung injury: Pathogenetic mechanism and therapeutic implication","volume":"1","author":"Su","year":"2012","journal-title":"World J Crit Care Med"},{"key":"key20180107234954_b2-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-3083.2009.02255.x","article-title":"Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis","volume":"69","author":"Castellheim","year":"2009","journal-title":"Scand J Immunol"},{"key":"key20180107234954_b3-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jss.2013.10.009","article-title":"Fish-oil emulsion (omega-3 polyunsaturated fatty acids) attenuates acute lung injury induced by intestinal ischemia-reperfusion through Adenosine 5\u2032-monophosphate-activated protein kinase-sirtuin1 pathway","volume":"187","author":"Jing","year":"2014","journal-title":"J Surg Res"},{"key":"key20180107234954_b4-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/TA.0000000000000602","article-title":"Recombinant human brain natriuretic peptide ameliorates trauma-induced acute lung injury via inhibiting JAK\/STAT signaling pathway in rats","volume":"78","author":"Song","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"key":"key20180107234954_b5-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"12463","DOI":"10.1038\/srep12463","article-title":"Kallistatin protects against sepsis-related acute lung injury via inhibiting inflammation and apoptosis","volume":"5","author":"Lin","year":"2015","journal-title":"Sci Rep"},{"key":"key20180107234954_b6-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1586\/1744666X.2014.909730","article-title":"Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: An updated review","volume":"10","author":"Lu","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"key20180107234954_b7-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2119\/molmed.2014.00176","article-title":"Extracellular high-mobility group box 1 protein (HMGB1) as a mediator of persistent pain","volume":"20","author":"Agalave","year":"2015","journal-title":"Mol Med"},{"key":"key20180107234954_b8-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1517\/14728222.2014.863876","article-title":"Targeting HMGB1 in the treatment of sepsis","volume":"18","author":"Wang","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"key20180107234954_b9-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.285.5425.248","article-title":"HMG-1 as a late mediator of endotoxin lethality in mice","volume":"285","author":"Wang","year":"1999","journal-title":"Science"},{"key":"key20180107234954_b10-ijmm-39-02-0297","first-page":"245","article-title":"High mobility group box 1 protein as a late-acting mediator of acute lung inflammation","volume":"17","author":"Lutz","year":"2004","journal-title":"Int J Occup Med Environ Health"},{"key":"key20180107234954_b11-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1073\/pnas.2434651100","article-title":"Reversing established sepsis with antagonists of endogenous high-mobility group box 1","volume":"101","author":"Yang","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107234954_b12-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"21052","DOI":"10.1073\/pnas.1216195109","article-title":"Human macrophage and dendritic cell-specific silencing of high-mobility group protein B1 ameliorates sepsis in a humanized mouse model","volume":"109","author":"Ye","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107234954_b13-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10456-008-9093-5","article-title":"Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1)","volume":"11","author":"van Beijnum","year":"2008","journal-title":"Angiogenesis"},{"key":"key20180107234954_b14-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"C917","DOI":"10.1152\/ajpcell.00401.2005","article-title":"High mobility group box 1 protein interacts with multiple Toll-like receptors","volume":"290","author":"Park","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"key20180107234954_b15-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2119\/molmed.2011.00001","article-title":"Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14","volume":"19","author":"Kim","year":"2013","journal-title":"Mol Med"},{"key":"key20180107234954_b16-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2013.09.010","article-title":"HMGB1 plays a critical role in vascular inflammation and lesion formation via toll-like receptor 9","volume":"231","author":"Hirata","year":"2013","journal-title":"Atherosclerosis"},{"key":"key20180107234954_b17-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.etp.2010.11.011","article-title":"Protective effect of Ulinastatin against murine models of sepsis: Inhibition of TNF-\u03b1 and IL-6 and augmentation of IL-10 and IL-13","volume":"64","author":"Cao","year":"2012","journal-title":"Exp Toxicol Pathol"},{"key":"key20180107234954_b18-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.intimp.2013.09.004","article-title":"Ulinastatin is a novel candidate drug for sepsis and secondary acute lung injury, evidence from an optimized CLP rat model","volume":"17","author":"Wang","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"key20180107234954_b19-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/TA.0b013e318223c20f","article-title":"Ulinastatin protects pulmonary tissues from lipopolysaccharide-induced injury as an immunomodulator","volume":"72","author":"Gao","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"key":"key20180107234954_b20-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.intimp.2015.09.028","article-title":"Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK\/NF-\u03baB pathway","volume":"29","author":"Li","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"key20180107234954_b21-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jss.2012.10.043","article-title":"Ulinastatin improves survival of septic mice by suppressing inflammatory response and lymphocyte apoptosis","volume":"182","author":"Huang","year":"2013","journal-title":"J Surg Res"},{"key":"key20180107234954_b22-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.phrs.2009.04.007","article-title":"Penehyclidine hydrochloride attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway","volume":"60","author":"Shen","year":"2009","journal-title":"Pharmacol Res"},{"key":"key20180107234954_b23-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jss.2014.11.031","article-title":"Ketamine reduces lipopolysaccharide-induced high-mobility group box-1 through heme oxygenase-1 and nuclear factor erythroid 2-related factor 2\/p38 mitogen-activated protein kinase","volume":"194","author":"Wang","year":"2015","journal-title":"J Surg Res"},{"key":"key20180107234954_b24-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3892\/ijmm.2013.1322","article-title":"Ulinastatin suppresses lipopolysaccharide-induced prostaglandin E2 synthesis and nitric oxide production through the downregulation of nuclear factor-\u03baB in BV2 mouse microglial cells","volume":"31","author":"Sung","year":"2013","journal-title":"Int J Mol Med"},{"key":"key20180107234954_b25-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.intimp.2015.04.002","article-title":"Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4\/NF-kappaB pathway","volume":"26","author":"Feng","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"key20180107234954_b26-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10753-015-0127-z","article-title":"Esculin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of TLR\/NF-\u03baB pathways","volume":"38","author":"Tianzhu","year":"2015","journal-title":"Inflammation"},{"key":"key20180107234954_b27-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front Immunol"},{"key":"key20180107234954_b28-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jss.2012.07.017","article-title":"Dexmedetomidine inhibits the secretion of high mobility group box 1 from lipopolysaccharide-activated macrophages in vitro","volume":"181","author":"Chang","year":"2013","journal-title":"J Surg Res"},{"key":"key20180107234954_b29-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1016\/j.jss.2012.02.012","article-title":"Magnesium sulfate inhibits the secretion of high mobility group box 1 from lipopolysaccharide-activated RAW264.7 macrophages in vitro","volume":"179","author":"Liu","year":"2013","journal-title":"J Surg Res"},{"key":"key20180107234954_b30-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jss.2012.04.045","article-title":"Magnesium deficiency promotes secretion of high-mobility group box 1 protein from lipopolysaccharide-activated macrophages in vitro","volume":"180","author":"Liu","year":"2013","journal-title":"J Surg Res"},{"key":"key20180107234954_b31-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jss.2013.08.015","article-title":"Penehyclidine hydrochloride inhibits the release of high-mobility group box 1 in lipopolysaccharide-activated RAW264.7 cells and cecal ligation and puncture-induced septic mice","volume":"186","author":"Yang","year":"2014","journal-title":"J Surg Res"},{"key":"key20180107234954_b32-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"e29053","DOI":"10.1371\/journal.pone.0029053","article-title":"Safety of postoperative administration of human urinary trypsin inhibitor in lung cancer patients with idiopathic pulmonary fibrosis","volume":"6","author":"Yamauchi","year":"2011","journal-title":"PLoS One"},{"key":"key20180107234954_b33-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1517\/13543781003649533","article-title":"Urinary trypsin inhibitor as a therapeutic option for endotoxin-related inflammatory disorders","volume":"19","author":"Inoue","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"key":"key20180107234954_b34-ijmm-39-02-0297","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.etp.2004.09.001","article-title":"Selected biochemical parameters and ultrastructural picture of pancreas due to Ulinastatin treatment of experimental acute pancreatitis","volume":"56","author":"Maciejewski","year":"2005","journal-title":"Exp Toxicol Pathol"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijmm.2016.2828\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T22:38:41Z","timestamp":1601246321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2016.2828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,13]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,12,13]]},"published-print":{"date-parts":[[2017,2]]}},"alternative-id":["10.3892\/ijmm.2016.2828"],"URL":"https:\/\/doi.org\/10.3892\/ijmm.2016.2828","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,13]]}}}